Bone mineral density, kidney function and participant‐reported outcome measures in women who switch from tenofovir disoproxil emtricitabine and a nonnucleoside reverse transcriptase inhibitor to abacavir, lamivudine and dolutegravir

Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients

AIDS ◽

10.1097/qad.0b013e328328f789 ◽

2009 ◽

Vol 27 (7) ◽

pp. 817-824 ◽

Cited By ~ 171

Author(s):

Claudine Duvivier ◽

Sami Kolta ◽

Lambert Assoumou ◽

Jade Ghosn ◽

Sylvie Rozenberg ◽

...

Keyword(s):

Bone Mineral Density ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Bone Mineral ◽

Transcriptase Inhibitor ◽

Mineral Density ◽

Reverse Transcriptase Inhibitor ◽

Hiv 1

Bone Mineral Density Effects of Randomized Regimen and Nucleoside Reverse Transcriptase Inhibitor Selection from ACTG A5142

HIV Clinical Trials ◽

10.1310/hct1405-224 ◽

2013 ◽

Vol 14 (5) ◽

pp. 224-234 ◽

Cited By ~ 19

Author(s):

Jeannie S. Huang ◽

Michael D. Hughes ◽

Sharon A. Riddler ◽

Richard H. Haubrich ◽

Keyword(s):

Bone Mineral Density ◽

Reverse Transcriptase ◽

Bone Mineral ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Mineral Density ◽

Density Effects ◽

Initial highly-active antiretroviral therapy with a protease inhibitor versus a nonnucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect metaanalyses

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70040-3 ◽

2007 ◽

Vol 2007 ◽

pp. 61-62

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Highly Active Antiretroviral Therapy ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing nonnucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: openlabel randomised trial

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70039-7 ◽

2007 ◽

Vol 2007 ◽

pp. 60-61

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Randomised Trial ◽

Transcriptase Inhibitor ◽

Faculty Opinions recommendation of Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1054717.506631 ◽

2006 ◽

Author(s):

Deanna Kroetz

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Gene Variants ◽

Drug Transporter ◽

Enzyme Gene ◽

Metabolizing Enzyme ◽

Efavirenz Is a Potent Nonnucleoside Reverse Transcriptase Inhibitor of HIV Type 1 Replication in Microgliain Vitro

AIDS Research and Human Retroviruses ◽

10.1089/088922200750006056 ◽

2000 ◽

Vol 16 (15) ◽

pp. 1527-1537 ◽

Cited By ~ 9

Author(s):

Andrew V. Albright ◽

Susan Erickson-Viitanen ◽

Michael O'Connor ◽

Ian Frank ◽

Marlene M. Rayner ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Hiv Type 1 ◽

Drug Transporter and Metabolizing Enzyme Gene Variants and Nonnucleoside Reverse-Transcriptase Inhibitor Hepatotoxicity

Clinical Infectious Diseases ◽

10.1086/507101 ◽

2006 ◽

Vol 43 (6) ◽

pp. 779-782 ◽

Cited By ~ 68

Author(s):

M. D. Ritchie ◽

D. W. Haas ◽

A. A. Motsinger ◽

J. P. Donahue ◽

H. Erdem ◽

...

Keyword(s):

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Gene Variants ◽

Drug Transporter ◽

Enzyme Gene ◽

Metabolizing Enzyme ◽

Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy

Medicine ◽

10.1097/md.0000000000002844 ◽

2016 ◽

Vol 95 (9) ◽

pp. e2844 ◽

Cited By ~ 24

Author(s):

Sumanth Karamchand ◽

Rory Leisegang ◽

Michael Schomaker ◽

Gary Maartens ◽

Lourens Walters ◽

...

Keyword(s):

Risk Factors ◽

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Incident Diabetes ◽

First Line ◽

Effects of denosumab on fracture and bone mineral density by level of kidney function

Journal of Bone and Mineral Research ◽

10.1002/jbmr.403 ◽

2011 ◽

Vol 26 (8) ◽

pp. 1829-1835 ◽

Cited By ~ 198

Author(s):

Sophie A Jamal ◽

Östen Ljunggren ◽

Catherine Stehman-Breen ◽

Steven Ron Cummings ◽

Michael R McClung ◽

...

Keyword(s):

Bone Mineral Density ◽

Kidney Function ◽

Bone Mineral ◽

Mineral Density

Estimating the Proportion of Bone Mineral Density Loss in Patients with Normal Kidney Function among South Indian Population

Indian Journal of Public Health Research & Development ◽

10.37506/ijphrd.v12i3.16125 ◽

2021 ◽

Keyword(s):

Bone Mineral Density ◽

Kidney Function ◽

Bone Mineral ◽

Indian Population ◽

South Indian Population ◽

Normal Kidney ◽

Mineral Density ◽

Bone Mineral Density Loss ◽

Normal Kidney Function ◽

South Indian